Exposure of the Fu5 rat hepatoma cell line to glucocorticoids, such as dexamethasone and hydrocortisone, suppressed the growth rate and final density of cells grown in the presence of serum. This hormonal effect was proportional to receptor occupancy and affinity and, in addition, the glucocorticoid antagonist RU38486 prevented this response. Two classes of dexamethasone-resistant variants that failed to be growth inhibited were recovered from ethyl methylsulfonate-mutagenized populations by continuous culture in the presence of 1 ,uM dexamethasone. The first class, represented by the EDR3 subclone, was completely glucocorticoid unresponsive and failed to express receptor transcripts. The second class, represented by the EDR1, EDR5, and EDR7 subclones, possessed significant levels of glucocorticoid receptor but were only partially glucocorticoid responsive when stimulated with saturating levels of hormone. Introduction of functional glucocorticoid receptor genes into both classes of dexamethasone-resistant variants by a recombinant retrovirus expression vector restored glucocorticoid responsiveness and suppression of cell growth. A hypersensitive variant (BDS1), recovered by bromodeoxyuridine selection, was fully glucocorticoid responsive, and its inhibition of proliferation was more acutely regulated by dexamethasone. Taken together, our results established that the inhibition of proliferation in Fu5 rat hepatoma cells represents a new glucocorticoid response that requires the expression of a functional glucocorticoid receptor.
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The regulation of normal and tumor cell growth is mediated by a dynamic balance between both positive and negative acting stimuli. For example, cellular escape from regulated growth inhibition or induction of growth-promoting processes are thought to be components of the complex series of events which occur during neoplastic transformation (19) . Moreover, the hormone-regulated proliferation of certain tumor cell types can be correlated with changes in expression of combinations of growth inhibitors and stimulators (10, 26) . The role of extracellular growth factors in stimulating cellular proliferation is a well-documented phenomenon; however, relatively less is known about inhibitory factors or their mechanisms of action. Growth-inhibiting factors include a wide range of extracellular hormone and hormone-like signalling molecules such as steroids, transforming growth factor type beta, tumor necrosis factor, lymphotoxin, and interferons as well as intracellular activities assigned to putative tumor-suppressing genes (12, 33) . Evidence also suggests that some growth inhibitors exert their effects by blocking the action of stimulatory growth factors or their receptors (5, 40, 50) . Many specific growth-inhibitory substances have been identified, but their modes of action have not been clearly delineated.
The in vivo administration of glucocorticoids to immature animals causes a dramatic suppression of somatic growth (55) . In addition, certain tumors have been shown to be sensitive to the inhibitory effects of glucocorticoids (24, 37, 47) . Moreover, many different cell types, both normal and transformed, have been shown to be sensitive to the growthinhibitory effects of glucocorticoid in vitro (2, 11, 12) . The effects of glucocorticoids on cellular proliferation appear to be particularly pronounced in hepatic tissue. For example, * Corresponding author. low doses of cortisone given to weanling rats results in a rapid and reversible cessation of DNA synthesis in growing normal liver tissue independent of the effects of glucocorticoids on growth hormone levels (21, 22) . Interestingly, regenerating liver was shown to be less sensitive to the inhibitory effects of glucocorticoids and to display a concomitant reduction in cytosolic glucocorticoid receptor levels during the regeneration process itself (6, 31) . In addition, normal adult rat hepatocytes as well as several hepatoma cell lines have been shown to be growth inhibited by glucocorticoids (2, 30, 44, 49) . One recent study suggests that glucocorticoids can stimulate the production of a factor from rat fetal hepatocytes capable of blocking the mitogenic stimulation of insulinlike growth factor (43) . However, little is known about the cellular requirements or molecular events responsible for the glucocorticoid inhibition of cellular proliferation in liver and liver-derived cells.
The Fu5 subclone of the H35 Reuber rat hepatoma has been previously reported to be growth inhibited by physiological doses of glucocorticoids (49) . These cells are a relatively differentiated hepatoma line and are highly glucocorticoid responsive (9) . In the following study we utilized the Fu5 cell line as a target for genetic selections to obtain subclones which were either resistant or hypersensitive to the growth-inhibitory actions of glucocorticoids. Our results demonstrated that resistance to glucocorticoid-mediated growth inhibition resulted from the total or partial loss of glucocorticoid receptor function and that the inhibition of cellular proliferation represents a new glucocorticoid receptor-mediated response. (1, 000 Ci/mmol), [a-32P]dCTP (3, 000 Ci/mmol), and nick translation kits were purchased from Amersham Corp., Arlington Heights, Ill. Culture-grade epidermal growth factor and highly purified basic fibroblast growth factor were both obtained from Collaborative Research, Bedford, Mass. Bovine insulin (25 U/mg) was purchased from GIBCO Laboratories, Santa Clara, Calif. Pansorbin was obtained from Calbiochem-Behring, LaJolla, Calif., and Kodak X-ray film was purchased from Merry X-Ray Chemical Corp., Burlingame, Calif. RU38486 was generously supplied by Roussel-UCLAF, Romainville, France. The anti-rat albumin antisera was obtained from Organon Teknika, Malvern, Pa. The anti-plasminogen activator-inhibitor antiserum (7, 17) was a generous gift from Thomas D. Gelehrter, University of Michigan Medical School, Ann Arbor, and the anti-alpha1-acid glycoprotein antibodies (42) was a generous gift John Taylor, Gladstone Foundation Laboratories, San Francisco, Calif. All other reagents used were of the highest possible purity.
MATERIALS AND METHODS

Materials
Cells and method of culture. The Fu5 cell line was a kind gift from Jerry A. Peterson, John Muir Research Institute, Walnut Creek, Calif.; the origin of this cell line has been previously described (9) . The Fu5 cell line and its derived subclones (BDS1, EDR1, EDR3, EDR5, and EDR7) were routinely grown in Dulbecco modified Eagle medium (DME)/F12 (50:50) supplemented with 10% fetal calf serum (Hyclone Laboratories) and nonessential amino acids. For serum-free experiments, all cells were cultured in a serumfree base consisting of DME/F12 (50:50) supplemented with nonessential amino acids, trace elements, and linoleic acid (84 ng/ml). The VDG12*2 cell line was a generous gift from Paul J. Godowski and Keith R. Yamamoto, University of California, San Francisco. These cells carry a packagingdefective helper virus and externalize a recombinant retrovirus containing RNA sequences for the rat glucocorticoid receptor gene linked to the neomycin resistance gene in the DOL-vector (29) . BALB/c 3T3 cells (clone A31) were obtained from the American Type Culture Collection, Rockville, Md. The VDG12i2 and BALB/c 3T3 cell lines were cultured in DME supplemented with 10% calf serum. All cells were grown on Falcon tissue culture plates (Becton Dickinson Labware, Oxnard, Calif.) at 37°C in a humidified atmosphere of air-CO2 (95:5%).
Selection of subclones hypersensitive to dexamethasoneinduced growth inhibition. FuS cells were passaged at 10,000 cells per cm2 on 100-mm tissue culture plates in serumsupplemented media. After 48 h of culture, the cells were exposed to 10-6 M dexamethasone for 24 h, bromodeoxyuridine was added to a final concentration of 5 x 10-6 M, and the cells were cultured under dark conditions for an additional 48 h. The cell culture medium was then replaced with 9 ml of phosphate-buffered saline, and the cells were exposed to fluorescent light for 90 min from two 15-W cool white fluorescent bulbs set 3 to 4 cm from the surface of the cells. After exposure to the light source, >99o of the cells died within 48 h. Surviving colonies were cultured and specific subclones were harvested from the plate. Fifteen subclones were subsequently screened for hypersensitivity to dexamethasone-induced growth inhibition, and the most sensitive subclone was designated BDS1.
In vitro mutagenesis and selection of dexamethasone-resistant cell lines. FuS cell populations were mutagenized with ethyl methylsulfonic acid, and dexamethasone-resistant variants that failed to be growth inhibited in the presence of glucocorticoids (denoted EDR) were recovered out as previously described (15) . Briefly, mutagenized cell populations were cultured continuously for 11 months in 1 ,M dexamethasone and single cell-derived lines were recovered by dilution subcloning.
Recovery of conditioned media. Hormone-induced and uninduced EDR3 hepatoma cells were plated at 3 x 10' cells per 100-mm plate and subsequently cultured for 48 h in serum-containing medium. The cells were then washed two times with DME and cultured in 15 ml of serum-free base in the presence or absence of 10-6 M dexamethasone. When appropriate, dexamethasone was added 8 h prior to the washing of cells. After 72 h, the conditioned media were removed and clarified of floating cells by centrifugation for 5 min at 600 x g. Dexamethasone (1 ,uM) was then added to the media not previously exposed to hormone. This compensated for the weak progression activity of glucocorticoids on BALB/c 3T3 cells. The media were then tested for ability to induce DNA synthesis in quiescent monolayers of BALB/c 3T3 cells as described below.
DNA synthesis assays. Total incorporation of [3H]thymidine was determined from a modified protocol previously described (48) . Briefly, Fu5 cells grown in 24-multiwell plates (as described under proliferation assays) were exposed for 72 h to various concentrations of dexamethasone in serum-supplemented medium. The medium was then removed and replaced with serum-supplemented medium containing dexamethasone and [3H]thymidine (10 ,uCi/ml).
After 1 h, the cells were washed two times with cold 10% trichloroacetic acid and subsequently exposed to 300 ,u of 0.2 M NaOH containing 40 ,ug of salmon sperm DNA per ml. After shaking for 10 min, the radioactivity in 100-pdl samples was analyzed by liquid scintillation. The incorporated [3H]thymidine was normalized for the total cell number per well as determined by DNA content.
BALB/c 3T3 cells were routinely passaged at 25,000 cells per well and grown to confluence in medium supplemented with 5% calf serum. After density-induced cell cycle arrest was attained, the cells were washed two times with DME and exposed to 0.2 ml of serum-free base containing basic fibroblast growth factor (2 ng/ml). After 7-h exposure to basic fibroblast growth factor, the competent cells were exposed to 0.5 ml of conditioned media or defined experimental media containing various growth factors (10 ng of epidermal growth factor or 10 ,ug of insulin per ml or both) in the presence of S pCi of [3H]thymidine per ml. After 24 h the total incorporation of [3H]thymidine was determined as described above.
Cell proliferation assays. FuS and its derived subclones were routinely passaged at a cell density of 10,000 or 20,000 (serum-free experiments) cells per cm2 onto Multiwell plates in the presence of serum-supplemented medium. After 48 h the cell medium was changed to the indicated experimental conditions. For serum-free experiments, the cells were washed two times with DME prior to exposure to experimental conditions; at designated times during the course of an experiment, the medium was aspirated from each well, and cells were subsequently fixed in 70% ethanol. Cell number in each well was calculated by determining total DNA content as previously described (14, 23 Immunoprecipitation and electrophoretic analysis. Immunoprecipitations of the extracellular fractions were carried out by using a highly sensitive staphylococcus A-immunoadsorption procedure that detects proteins in the virtual absence of nonspecific background (25, 41) . Immunoprecipitated proteins bound to final staphylococcus A pellets were electrophoretically fractionated in SDS-polyacrylamide gels and analyzed by fluorography as previously described (13) .
Infection of ceU lines with a retroviral vector containing the rat glucocorticoid receptor gene. A 3-ml portion of VDG12t42 cell conditioned medium, containing recombinant virions carrying RNA for the intact rat glucocorticoid receptor gene linked to the bacterial neomycin resistance gene, was filtered and placed onto 50% confluent 100-mm dishes of various FuS-derived cell lines. Polybrene was added to each dish at a final concentration of 8 ,ug/ml, the cells were incubated for 2 h, and the medium was replaced with normal culture medium. After 24 h the cells were incubated with medium containing G418 (900 ,ug/ml) for 10 days to select for neomycin-resistant cells. Under these conditions approximately 1 to 5% of the infected population acquired resistance to G418. A stable population of G418-resistant cells was recovered and cultured in the absence of selective medium for 1 week before use. 8, 1988 density one-half that of untreated cells, well below the normal level of confluency. Glucocorticoids, therefore, affect two proliferative properties of Fu5; both the growth rate and final cell density attained were significantly reduced. Importantly, under our culture conditions, hormone treatment did not impair global RNA or protein synthesis, nor does it cause a loss of cell viability (data not shown).
RESULTS
Glucocorticoid inhibition of Fu5 proliferation requires glucocorticoid receptor occupancy and function. To determine the relationship between glucocorticoid receptor occupancy and the hormone-induced inhibition of growth rate, Fu5 cells were exposed to various concentrations of dexamethasone for 72 h. Final cell density and DNA synthesis (monitored by [3H]thymidine incorporation) were determined and compared with the level of [3H]dexamethasone specifically bound to high-affinity glucocorticoid receptors (monitored by a glass-fiber filter assay) over an identical range of dexamethasone concentrations. The dose response for growth inhibition is shifted to concentrations of hormone lower than that required for comparable levels of hormone binding (Fig. 2a) . For example, 20% receptor occupancy (2.5 nM) elicited a half-maximal inhibition of cellular proliferation. A similar hypersensitive response to receptor occupancy has been observed for other Fu5 glucocorticoidinducible genes (35) . Importantly, the dose-response curves for inhibition of [3H]thymidine incorporation and final cell density were nearly identical, indicating that changes in cell number accurately reflect the changes in the rate of de novo DNA synthesis. Moreover, these results demonstrated that In a complementary experiment, Fu5 cells were exposed to various concentrations of RU38486, a potent antagonist of glucocorticoid receptor action (38) , in the presence of 20 nM unlabeled dexamethasone. Total cell number was determined after 4 days of exposure to RU38486, and the final cell density was calculated as the percent maximal cell density in the absence of added steroid. In parallel, an identical dose range of RU38486 was tested for competition with 20 mM [3H]dexamethasone for Fu5 cytosolic glucocorticoid receptors; steroid binding was monitored by a glass-fiber filter assay. The amount of [3H]dexamethasone specifically bound at each competing concentration of RU38486 was then calculated as the percent maximal bound hormone. Direct comparisons of each curve revealed that RU38486 antagonized the dexamethasone-mediated inhibition of Fu5 cell proliferation in proportion to the occupancy of glucocorticoid receptors by dexamethasone (Fig. 2b) . Taken together, our results indicated that functional glucocorticoid receptors are required for hormonal inhibition of growth. Consistent with this notion, the ability of different steroids to inhibit Fu5 cellular proliferation strongly correlated with their known glucocorticoid agonist properties in this cell line. For example, aldosterone acted as an strong agonist, testosterone showed weak antagonistic effects, progesterone displayed both antagonistic action in the presence of dexamethasone and weak agonistic effects when added alone, while vitamin D3 and 17-p-estradiol had no effect (data not shown). Fig. 1 and incubated with the indicated concentrations of dexamethasone (DEX) for 3 days. Cell density was determined by assaying total DNA content (Fig. 1) (Fig. 3a versus 3b) . In contrast, EDR1, EDR3, EDR5, and EDR7 cells display a glucocorticoidresistant phenotype and are not growth inhibited in the presence of hormone (Fig. 3c to f) . Thus, these resistant variants are likely to be deficient in one or more glucocorticoid-induced events that mediate Fu5 growth inhibition.
Glucocorticoid responsiveness of Fu5 and its derived variant subclones. To assess the glucocorticoid responsiveness of the growth variants, the dexamethasone-mediated induction of tyrosine aminotransferase (TAT) RNA transcripts was examined by using a cytoblot assay. BDS1, EDR1, EDR5, and EDR7 competently induced TAT RNA after exposure to dexamethasone, while EDR3 failed to express TAT transcripts in a hormone-regulated manner (Table 1) . A second cytoplasmic glucocorticoid-inducible gene product, glutamine synthetase activity, was also tested. Only Fu5 and the hypersensitive variant BDS1 were able to elicit a significant dexamethasone-induced induction of glutamine synthetase activity ( (Fig.  4) . Moreover, in a manner similar to TAT, all of the variants except EDR3 (PAI panel, lane G versus H) expressed elevated levels of PAI in a dexamethasone-dependent fashion (Fig. 4) (Table 2) . Although BDS1, EDR1, EDR5, and EDR7 cells expressed levels of receptor transcripts greater than the parental levels, the amount of specific bound hormone did not always precisely correlate with the amount of expressed receptor transcripts. Only EDR3 failed to show significant levels of glucocorticoid receptor transcripts and is therefore a true glucocorticoid receptor-"minus" variant. This is in agreement with earlier data which indicated that EDR3 possessed little or no high-affinity binding for glucocorticoids (15) .
Introduction of functional glucocorticoid receptor into a receptor-minus celi line confers hormonafly induced growth inhibition and negative regulation of secreted mitogenic activity. To demonstrate that glucocorticoid receptor function is required for the inhibition of cellular proliferation, we introduced a functional rat glucocorticoid receptor gene into EDR3 cells. This was accomplished by infection with a retroviral vector containing RNA for the rat glucocorticoid receptor gene linked to the bacterial neomycin resistance gene. The virally infected G418-resistant cell population (E3G) as well as EDR3 and Fu5 cells were analyzed for expression of glucocorticoid receptor transcripts. Wild-type Fu5 cells display significant levels of glucocorticoid receptor RNA (Fig. 5a) , while transcript levels in EDR3 are at or near background. The infected E3G cell population expressed levels of receptor RNA nearly equal to those observed for FuS. Introduction of the glucocorticoid receptor into variant EDR3 restored specific binding of 15 nM [3H]dexamethasone (Fig. 5b) to 60% the level observed in FuS. Importantly, introduction of the receptor gene restored the glucocorticoid-mediated growth inhibition. After 4 days in culture, EDR3 displayed no sensitivity to glucocorticoidmediated growth inhibition, while E3G shows significant glucocorticoid-dependent growth inhibition (Fig. 5c) . Interestingly, in E3G cell populations dexamethasone inhibited the activity of extracellular factors mitogenic for BALB/c 3T3 cells not observed in EDR3 (Fig. Sd) . This glucocorticoid-suppressible extracellular mitogenic activity is also present in Fu5 and BDS1 and appears to be a thermal and acid-stable protein(s) with cotransforming activity (P. W. Cook, C. P. Edwards, and G. L. Firestone, manuscript in preparation). Thus, introduction of a functional glucocorticoid receptor into the receptor-minus EDR3 subclone confers dexamethasone binding activity and glucocorticoid inhibition of both cellular proliferation and the activity of secreted factors mitogenic for quiescent fibroblasts. These results unambiguously demonstrate that the glucocorticoid inhibition of cellular proliferation and extracellular growth factor activity required receptor function.
Introduction of functional glucocorticoid receptors into partiadly responsive clones restores hormone responsiveness. The partial glucocorticoid responsiveness of EDR1, EDR5, and EDR7 suggests that a common factor may be required for the normal induction of hormone-regulated products that fail to 8, 1988 1455 be expressed in these variants (AGP, glutamine synthetase, growth-inhibitory products). Infection of EDR1, EDR5, and EDR7 with the recombinant retrovirus containing RNA for a functional glucocorticoid receptor gene was used to determine whether the defect resulting in partial hormone responsiveness was due to subtle mutations in the receptor itself. Infected variant cell populations denoted (E1G, E5G, and E7G, as well as E3G cells described earlier) were cultured in the presence or absence of dexamethasone for 4 days and total cell number per well was determined by assaying total DNA. E1G, E5G, and E7G now show glucocorticoid-induced growth inhibition in a manner similar to that obseryed for wild-type Fu5 (Fig. 6a) . As a control, receptors were also introduced into the hypersensitive variant (BiG), resulting in a slightly greater degree of growth inhibition than observed for uninfected BDS1.
To test for the restoration of other glucocorticoid-regulated products, infected variants were cultured in the presence or absence of dexamethasone for 24 h and radiolabeled with [35S] methionine for the final 6 h of the hormonal exposure, and the radiolabeled culture media were then immunoprecipitated for AGP. The hormonal induction of secreted AGP was restored (Fig. 6b ) in all infected variants that had not previously displayed this response (Fig. 4) (16, 20, 51, 52) , the class of Fu5-derived variants represented by EDR1, EDR5, and EDR7 displayed partial pleiotropy with respect to their steroid-responsive domain. Certain combinations of glucocorticoid-regulated genes failed to be induced, whereas the remaining set of responses were regulated normally. For example, in EDR1, EDR5, and EDR7 cells, the dexamethasone-regulated inhibition of cellular proliferation and induction of glutamine synthetase and AGP were not observed, while the expression of PAI and TAT were efficiently induced at saturating levels of dexamethasone. Surprisingly, introduction of functional glucocorticoid receptors also restored the wild-type phenotype in these variants, suggesting that their glucocorticoid receptors may have been defective in a subtle manner that allowed a selective expression of certain glucocorticoid-mediated responses. Alternatively, these cells may require higher concentrations of receptor for complete hormone responsiveness. In either case, that proliferation and a select number of certain other glucocorticoid-inducible genes failed to respond to hormone treatment suggests that the gene expression events that mediate growth inhibition may be linked in part to the expression of other steroid-inducible gene products.
Given current concepts of glucocorticoid hormone action, which has demonstrated a transcriptional mechanism of action (1, 56) , likely mechanisms by which dexamethasone can directly inhibit Fu5 cell proliferation include the stimulated synthesis of growth inhibitors, the reduced synthesis of specific growth-promoting factors, or a combination of both effects. For example, in cultured human mammary tumor cells (10, 26) , estrogen simultaneously inhibits the production of secreted transforming growth factor type beta (a proliferation inhibitor) and stimulates the release of mitogenic transforming growth factor type alpha. Conceivably, glucocorticoid-induced factors may also regulate the functional expression of cellular components or receptors that respond to extracellular mitogenic activities. Indeed, glucocorticoids have been shown to down-regulate insulin-binding activity (4) , while insulin, acting through the insulin receptor, has been reported to be a potent mitogen for the H35 and H4-EII-C3 hepatoma cells (27, 28, 34, 39) as well as for Fu5 cells (P. W. Cook and G. L. Firestone, unpublished data). We have also obtained data which suggest that glucocorticoids may be regulating the activity of mitogenic polypeptide factors secreted by both Fu5 and BDS1 cells. Potential disruptions of the growth-stimulating autocrine pathways by glucocorticoids are being explored in these rat hepatoma cell lines.
It will be interesting to determine whether the ability of glucocorticoids to regulate the proliferation of hepatoma cells can be correlated to a specific differentiation or tumorigenic state of liver-derived cells and whether this response is expressed in a tissue-specific manner. Indeed, we are beginning to test this notion in other tumor cells with specific hormone-responsive and unresponsive proliferative properties such as cultured rat mammary tumor cells. The selection of glucocorticoid-resistant variants was crucial to unambiguously establish the role of glucocorticoid receptors in the inhibition of Fu5 hepatoma cell proliferation. This genetic approach is being continued to recover variants that express fully functional glucocorticoid receptors but fail to be growth inhibited in the presence of hormone. The response of these variants to glucocorticoids at the molecular level will be used to genetically identify the key glucocorticoid-regulated hepatoma gene products responsible for mediating growth inhibition in the hypersensitive BDS1 subclone of Fu5.
